NCT00479050
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
Not specified
Clinical trial condition
Carcinoma
Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.
8,764 public trials
2,078 recruiting studies
Carcinoma trial results
NCT00192049
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- For additional information regarding investigative sites for this trial contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician Beersheba, Israel
- For additional information regarding investigative sites for this trial contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician Haifa, Israel
- For additional information regarding investigative sites for this trial contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician Jerusalem, Israel
- For additional information regarding investigative sites for this trial contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician Kfar Saba, Israel
Completed
Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma
NCT00076609
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- Stanford Hospital and Clinics Stanford, California, United States
- Yale University New Haven, Connecticut, United States
- VA Connecticut Cancer Center West Haven, Connecticut, United States
NCT00134186
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
- Locations
-
- Methodist Hospital Houston, Texas, United States
NCT00191503
- Conditions
- Adenocarcinoma, Carcinoma, Neoplasms, +2 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Calgary, Alberta, Canada
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Edmonton, Alberta, Canada
NCT00191711
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- For additional information regarding investigative sites for this trial, please call 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559), Mon - Fri 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your physician Sesto Fiorentino, Florence, Italy
NCT00191750
- Conditions
- Carcinoma, Carcinoma, Small Cell, Neoplasms, +2 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Aurora, Colorado, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Chapel Hill, North Carolina, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Dallas, Texas, United States
NCT00386984
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
- Locations
-
- University Medical Center Freiburg Freiburg im Breisgau, Baden-Wurttemberg, Germany
NCT00101842
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +2 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Dallas, Texas, United States
Completed
Study the Expression of Annexin A1 and Its Potential Usage as a Prognostic Marker in Oral Cancer
NCT00364715
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Neoplasms, +4 more
- Locations
-
- National Taiwan University Hospital Taipei, Taiwan